Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Cardiogenesis Reports Third Quarter 2010 Results

November 3, 2010 5:35 pm | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Nov. 3, 2010 /- Cardiogenesis Corporation (OTCQB: CGCP), a leading developer of surgical products used in the treatment of diffuse coronary artery disease, today reported financial results for its third quarter and first nine months ended September 30, 2010. Revenue for...

Study in NEJM Shows Novartis Drug Afinitor® Reduces Size of SEGAs, Benign Brain Tumors Associated with Tuberous Sclerosis

November 3, 2010 5:35 pm | by Bio-Medicine.Org | News | Comments

EAST HANOVER, N.J., Nov. 3, 2010 /- The New England Journal of Medicine (NEJM) today published a study that found patients taking Afinitor® (everolimus) tablets experienced a decrease in the size of their subependymal giant cell astrocytoma (SEGA), a benign brain tumor associated...

Medicare Bidding System for Medical Equipment Plagued by Flaws, Delays, Lack of Transparency

November 3, 2010 5:34 pm | by Bio-Medicine.Org | News | Comments

WASHINGTON, Nov. 3, 2010 /PRNewswire-USNewswire/ -- The inherent design flaws, long overdue announcement of winners, and lack of transparency in Medicare's controversial "competitive" bidding program for home medical equipment have made it difficult for homecare patients and providers to...

Advertisement

Aethlon Medical to Present at the Singular Research Fifth Annual 'Best of the Uncovereds Conference'

November 3, 2010 5:34 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Nov. 3, 2010 /- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD ), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, disclosed today that it will present tomorrow at the at the Singular Research Fifth Annual "Best of the...

Do we hide behind our reports? The challenge of directly communicating results to our patients

November 3, 2010 5:34 pm | by Diagnostic Imaging | News | Comments

“I hope my doctor can figure out why I've been having so much difficulty swallowing of late,” said the patient as I finished his upper GI study. During the procedure I clearly saw a large mass invading the lumen of Mr. Jones' esophagus but I kept this knowledge to myself as I made small...

Netsmart Technologies Software Supports Shawnee Mental Health Center Integrated Mental Health and Primary Care Initiative

November 3, 2010 12:33 pm | by Bio-Medicine.Org | News | Comments

GREAT RIVER, N.Y., Nov. 3, 2010 /- Netsmart Technologies, Inc., a leading provider of software and services for health and human services organizations, announced that one if its mental health provider customers, Shawnee (Ohio) Mental Health Center, is achieving positive results from a...

Sleeping pills not easy answer

November 3, 2010 12:32 pm | by Baylor College of Medicine | News | Comments

When sleep doesn't come easily, some people turn to what they think is an easy solution – sleeping pills. But according to a Baylor College of Medicine sleep expert, sleep medications – whether prescription or over-the-counter – shouldn't be taken lightly. "All...

Cocrystal Discovery Receives Awards for Its Novel Antiviral Drug Development Programs

November 3, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

SEATTLE, Nov. 3, 2010 /- Cocrystal Discovery, Inc., a biopharmaceutical company focused on the discovery and development of novel antiviral therapeutics for the treatment of serious and chronic viral diseases, announced today that it has received $733,438 in grants from the Qualified...

Advertisement

PhRMA CEO John Castellani Responds to Mid-Term Election, Stresses Importance of Innovation to Help Grow Economy

November 3, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Nov. 3, 2010 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani released the following statement and video regarding the mid-term election: Watch the Video "Congratulations to all of the candidates who...

Research Facility Expansion Will Create, Retain More than 150 Jobs in Chester County

November 3, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

HARRISBURG, Pa., Nov. 3, 2010 /PRNewswire-USNewswire/ -- A global contract research organization will expand its operations in Chester County and create more than 80 new jobs within three years, the Department of Community and Economic Development announced today. PPD Inc. is planning to...

IRS Awards $244,479 Grant to STB Lifesaving Technologies®

November 3, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., Nov. 3, 2010 /- STB Lifesaving Technologies ® today announced that it has been awarded a Qualifying Therapeutic Discovery Project (QTDP) grant from the U.S. government in the amount of $244,479.   The Qualifying Therapeutic Discovery Project was included in the...

Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania

November 3, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

BASKING RIDGE, N.J., Nov. 3, 2010 /- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Ellen McDonald, MBA, Senior Vice President and Chief Business Officer, will be presenting at IMPACT 2010 held at...

Champions Biotechnology Awarded $1.46 million in Grants

November 3, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

BALTIMORE, Nov. 3, 2010 /- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR ), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today received $1.46 million in grants as part of the Qualifying...

Advertisement

ACR Distributes Free High-Tech Mammography Education Tool to NY Facilities

November 3, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

RESTON, Va., Nov. 3, 2010 /PRNewswire-USNewswire/ -- The American College of Radiology (ACR) distributed 1,500 copies of the College's Mammography Case Review ( MCR5 ) educational CD-ROM free of charge to physicians in approximately 600 ACR-accredited mammography facilities throughout New...

Novus Scientific and Singapore Association of Plastic Surgeons (SAPS) Host the Inaugural Event of 'SOFTISSUE - The Issue of Soft Tissue,' Featuring James J. Chao, M.D., FACS, ...

November 3, 2010 8:35 am | by Bio-Medicine.Org | News | Comments

SINGAPORE, Nov. 3, 2010 /- Singapore company Novus Scientific Pte. Ltd today announced the successful hosting of Asia's 1st "SOFTISSUE – The Issue of Soft Tissue" educational series, together with the Singapore Association of Plastic Surgeons (SAPS) on 1st November 2010. This...

Cyberonics Announces Conference Call to Discuss Fiscal Year 2011 Second Quarter Financial Results

November 3, 2010 8:35 am | by Bio-Medicine.Org | News | Comments

HOUSTON, Nov. 3, 2010 /- Cyberonics, Inc. (Nasdaq: CYBX ) today announced that the company will report financial results for the second quarter ended October 29, 2010 of its fiscal year ending April 29, 2011 on Monday, November 22, 2010 at 8:00 AM ET.  The company will conduct a...

Georgia Tech Hosts Sickle Cell Disease Symposium

November 3, 2010 8:34 am | by Georgia Tech Institute of Technology | News | Comments

Georgia Tech will host the Sickle Cell Disease Symposium bringing together researchers, policy experts and community advocates to discuss the latest research and strategies for future success in combating this complex and debilitating blood disorder.

Caliper Life Sciences and Sony DADC Collaborate to Develop Plastic Microfluidic Solutions

November 3, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

HOPKINTON, Mass., Nov. 3, 2010 /- Caliper Life Sciences, Inc. (Nasdaq: CALP ), a leading provider of tools and services for drug discovery and life sciences research, today announced a collaboration with Sony DADC Austria AG for the co-development and manufacture of plastic consumables...

Cardiogenesis Receives Research Award From Federal Government

November 3, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Nov. 3, 2010 /- Cardiogenesis Corporation (OTCQB: CGCP), a leading developer of surgical products used in the treatment of diffuse coronary artery disease, today announced the receipt of a grant of approximately $244,500 from the Qualifying Therapeutic Discovery Project...

IDEV Technologies Announces FDA 510(k) Clearance for SUPERA VERITASâ„¢

November 3, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

WEBSTER, Texas, Nov. 3, 2010 /- IDEV Technologies, Incorporated (IDEV), an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance to market the SUPERA VERITAS...

Cleveland Clinic Unveils Top 10 Medical Innovations for 2011

November 3, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

CLEVELAND, Nov. 3, 2010 /- From pill-sized cameras to radioactive compounds that let doctors "see" inside a patient's brain, Cleveland Clinic's Top 10 Medical Innovations for 2011 showcases new techniques, therapies and approaches to treating a host of diseases. The list of breakthrough...

DNA Medicine Institute Receives Qualifying Therapeutic Discovery Grant

November 3, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass., Nov. 3, 2010 /- The DNA Medicine Institute, a biomedical research organization whose mission is to advance patient care, alleviate human suffering, and treat disease through innovation, has received a $222,999 grant from the U.S. government under the Qualifying...

Asia Pacific Pharma Companies Turning to High-Risk, High-Reward Drug Development, According to New Report from Thomson Reuters

November 2, 2010 11:33 pm | by Bio-Medicine.Org | News | Comments

PHILADELPHIA and LONDON, Nov. 3, 2010 /- Pharmaceutical companies in the Asia Pacific region are increasingly adapting their business models from the production of generic drugs towards more high-risk, high-return research and development, according to a new report released today by CMR...

Telik Awarded $1.2 Million in Grants for Qualifying Therapeutic Development Projects

November 2, 2010 7:34 pm | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Nov. 2, 2010 /- Telik, Inc. (Nasdaq: TELK ) a clinical stage drug development company focused on developing drugs to treat cancer, announced that it has been awarded grants totaling $1,222,396 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP)....

Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in...

November 2, 2010 7:33 pm | by Bio-Medicine.Org | News | Comments

BASKING RIDGE, N.J., Nov. 2, 2010 /- Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Steven L. Zelenkofske, D.O., F.A.C.C., Senior Vice President and Chief Medical Officer, presented an...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading